Literature DB >> 11052411

Adjunctive donepezil in attention deficit hyperactivity disorder youth: case series.

T E Wilens1, J Biederman, J Wong, T J Spencer, J B Prince.   

Abstract

Despite well-documented improvement in attention deficit hyperactivity disorder (ADHD) in youths with the available single and combined pharmacologic agents, a number of youths remain with residual symptomatology causing impairment in multiple domains. Recent work has suggested a potential cognitive-enhancing role of cholinergic agents in ADHD. We describe five cases of ADHD youths aged 8-17 years being treated for ADHD with the acetylcholinesterase inhibitor donepezil (Aricept), all of whom demonstrated improvement.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11052411     DOI： 10.1089/10445460050167322

Source DB:  PubMed          Journal:  J Child Adolesc Psychopharmacol        ISSN： 1044-5463            Impact factor:   2.576


  7 in total

Review 1.  Relevance of donepezil in enhancing learning and memory in special populations: a review of the literature.

Authors:  J Helen Yoo; Maria G Valdovinos; Dean C Williams
Journal:  J Autism Dev Disord       Date:  2007-01-13

Review 2.  Targeting the nicotinic cholinergic system to treat attention-deficit/hyperactivity disorder: rationale and progress to date.

Authors:  Alexandra S Potter; Geoffrey Schaubhut; Megan Shipman
Journal:  CNS Drugs       Date:  2014-12       Impact factor: 5.749

Review 3.  Cognitive enhancers for the treatment of ADHD.

Authors:  L Cinnamon Bidwell; F Joseph McClernon; Scott H Kollins
Journal:  Pharmacol Biochem Behav       Date:  2011-05-10       Impact factor: 3.533

Review 4.  Non-stimulant medications in the treatment of ADHD.

Authors:  Tobias Banaschewski; Veit Roessner; Ralf W Dittmann; Paramala Janardhanan Santosh; Aribert Rothenberger
Journal:  Eur Child Adolesc Psychiatry       Date:  2004       Impact factor: 4.785

Review 5.  Attention-deficit/hyperactivity disorder in older adults: prevalence and possible connections to mild cognitive impairment.

Authors:  Nikki Ivanchak; Kristen Fletcher; Gregory A Jicha
Journal:  Curr Psychiatry Rep       Date:  2012-10       Impact factor: 5.285

6.  Methylphenidate restores visual memory, but not working memory function in attention deficit-hyperkinetic disorder.

Authors:  Sinead M Rhodes; David R Coghill; Keith Matthews
Journal:  Psychopharmacology (Berl)       Date:  2004-09       Impact factor: 4.530

7.  Drug therapy of attention deficit hyperactivity disorder: current trends.

Authors:  Avinash De Sousa; Gurvinder Kalra
Journal:  Mens Sana Monogr       Date:  2012-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.